These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15992925)

  • 1. Decursin and PDBu: two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells.
    Kim HH; Ahn KS; Han H; Choung SY; Choi SY; Kim IH
    Leuk Res; 2005 Dec; 29(12):1407-13. PubMed ID: 15992925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of PKC and ROS in the cytotoxic mechanism of anti-leukemic decursin and its derivatives and their structure-activity relationship in human K562 erythroleukemia and U937 myeloleukemia cells.
    Kim HH; Sik Bang S; Seok Choi J; Han H; Kim IH
    Cancer Lett; 2005 Jun; 223(2):191-201. PubMed ID: 15896453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decursin: a cytotoxic agent and protein kinase C activator from the root of Angelica gigas.
    Ahn KS; Sim WS; Kim IH
    Planta Med; 1996 Feb; 62(1):7-9. PubMed ID: 8720379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells.
    Dong ZY; Ward NE; Fan D; Gupta KP; O'Brian CA
    Mol Pharmacol; 1991 Apr; 39(4):563-9. PubMed ID: 2017156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of c-Myc and Max in megakaryocytic and monocytic-macrophagic differentiation of K562 cells induced by protein kinase C modifiers: c-Myc is down-regulated but does not inhibit differentiation.
    Lerga A; Crespo P; Berciano M; Delgado MD; Cañelles M; Calés C; Richard C; Ceballos E; Gutierrez P; Ajenjo N; Gutkind S; León J
    Cell Growth Differ; 1999 Sep; 10(9):639-54. PubMed ID: 10511314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that a novel human differentiation-inhibiting protein blocks the dimethyl sulfoxide-induced differentiation of erythroleukemia cells by inhibiting the activation of membrane protein kinase C.
    Durkin JP; Chakravarthy B; Tremblay R; Jouishomme H; Whitfield JF; Biquard JM; Krsmanovic V
    Cancer Res; 1992 Nov; 52(22):6329-34. PubMed ID: 1423278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of protein kinase C in ethanol-induced activation of adenylyl cyclase.
    Rabbani M; Nelson EJ; Hoffman PL; Tabakoff B
    Alcohol Clin Exp Res; 1999 Jan; 23(1):77-86. PubMed ID: 10029206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
    Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW
    Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of megakaryocytic and erythroid properties in human leukemic cells.
    Tani T; Ylänne J; Virtanen I
    Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor signal transduction. Cell-type-specific activation and translocation of protein kinase C.
    Schütze S; Nottrott S; Pfizenmaier K; Krönke M
    J Immunol; 1990 Apr; 144(7):2604-8. PubMed ID: 2156927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of protein kinase C in expression of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.
    Uemura Y; Kobayashi M; Nakata H; Kubota T; Saito T; Bandobashi K; Taguchi H
    Int J Mol Med; 2005 Nov; 16(5):873-81. PubMed ID: 16211258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alpha1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells.
    Fuchs R; Stelzer I; Haas HS; Leitinger G; Schauenstein K; Sadjak A
    Ann Hematol; 2009 Oct; 88(10):989-97. PubMed ID: 19241077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubenimex (Bestatin), an aminopeptidase inhibitor, modulates protein kinase C in K562 cells.
    Kumano N; Sugawara S
    J Biol Regul Homeost Agents; 1992; 6(4):116-20. PubMed ID: 1296452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines.
    Shoji M; Fukuhara T; Winton EF; Berdel WE; Vogler WR
    Exp Hematol; 1994 Jan; 22(1):13-8. PubMed ID: 8282054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of protein kinase C suppresses induction of apoptosis in human prostatic carcinoma cells.
    Rusnak JM; Lazo JS
    Exp Cell Res; 1996 Apr; 224(1):189-99. PubMed ID: 8612685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer.
    Jiang C; Lee HJ; Li GX; Guo J; Malewicz B; Zhao Y; Lee EO; Lee HJ; Lee JH; Kim MS; Kim SH; Lu J
    Cancer Res; 2006 Jan; 66(1):453-63. PubMed ID: 16397261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-11 induces rapid PKC activation and cytosolic to particulate translocation of alpha and beta PKC isoforms in human erythroleukemia K562 cells.
    Spencer GC; Adunyah SE
    Biochem Biophys Res Commun; 1997 Mar; 232(1):61-4. PubMed ID: 9125152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C pathway is involved in transcriptional regulation of C-reactive protein synthesis in human hepatocytes.
    Ivashchenko Y; Kramer F; Schäfer S; Bucher A; Veit K; Hombach V; Busch A; Ritzeler O; Dedio J; Torzewski J
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):186-92. PubMed ID: 15539624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
    Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
    Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.